Target intelligence / Profile preview

Outer dynein arm-docking complex subunit 3 (ODAD3)

Target
ODAD3
Molecular classification
Structural protein, Axonemal docking complex component, Other
01

Overview

Outer dynein arm-docking complex subunit 3 (ODAD3; also known as CCDC151) is a structural protein that forms part of the heterotrimeric outer dynein arm-docking complex (ODA-DC), which is essential for the attachment and correct placement of the outer dynein arms on the axonemal doublet microtubules of motile cilia and flagella[1][2][3]. This complex, composed of three core subunits, including DC3 (ODAD3/CCDC151), establishes the periodic binding sites required for efficient ciliary and flagellar movement by ensuring cooperative and regular assembly of the dynein arms every 24 nm along the axoneme[1][2]. The function of ODAD3 is critical for cilia motility, and loss-of-function mutations in the CCDC151 gene result in impaired ciliary motion, causing disorders such as primary ciliary dyskinesia (PCD)[1]. ODAD3 is not a therapeutic target per se but is studied in the context of genetic diseases involving cilia dysfunction.

Other names
CCDC151Coiled-coil domain-containing protein 151CILD30ODA10MGC20983
02

Biological functions

Assembly and docking of outer dynein arms on motile cilia/flagellaRegulation of ciliary and flagellar motilityEstablishment of axonemal periodicity
03

Disease associations

Other (mutations cause primary ciliary dyskinesia and related ciliopathies)
04

Safety considerations

Loss or mutations may cause defects in ciliary motility leading to primary ciliary dyskinesia and respiratory tract issuesNo therapeutic targeting, so no established drug safety concerns
05

Biomarkers

Mutation of CCDC151/ODAD3 as a genetic biomarker for primary ciliary dyskinesia

Beyond the preview

Go deeper on Outer dynein arm-docking complex subunit 3 (ODAD3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Outer dynein arm-docking complex subunit 3 (ODAD3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call